https://www.selleckchem.com/pr....oducts/Temsirolimus.
46±0.69mm, 2.94±0.65mm, and 2.66±0.64mm at L1, L2, and L3, respectively. There was a significant reduction in SLEB measurement after compression therapy ( p values 0.008, 0.002, and 0.003 at L1, L2, and L3, respectively). The mean percentage reduction in SLEB at level of medial malleolus (mid level - 29.61±12.24) was higher than the other 2 sites (L1-22.45±15.83 and L3 were 27.57±12.34). Cutaneous ultrasound aids in accurate assessment of level and severity of edema. Hence, it can be utilized in trials to objectively assess the ade
Like
Comment
Share
